Cohance Lifesciences Ltd (COHANCE)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1021.00
% Change: 2.61% (Prev Close: 995.05)

Volume: 5,15,762
% Change: -89.56% (Prev Volume: 49,38,667)

Delivery: 1,59,107
Delivery % : 30.85
% Change: -91.02% (Prev Delivery: 17,71,916)

Turnover: 5,201 Lacs
% Change: -89.22% (Prev Turnover: 48,254)

πŸ’Ή EOD Valuation

P/E Ratio: 81.75
P/B Ratio: 15.32
Market Cap: 39063 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: COHANCE
Market Cap: 33689 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1360.00
52 Week Low: 856.30

All-Time High: 1360.00 Rs.
All-Time Low: 87.05 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.89% | -14.23% | -22.38% | -19.82% | 22.42%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 66.41%

Change (3Y | 1Y): 6.41% | 16.31%

Pledged %: 100.00%

FII Holding

FII Holding: 7.23%

Change (3Y | 1Y): -1.26% | -3.82%

DII Holding

DII Holding: 11.40%

Change (3Y | 1Y): 4.44% | -5.20%

Public Holding: 14.95%

🏦 Financial Strength

Debt to Equity: 0.16
Debt: 279.07 Rs. Cr.

Book Value: 66.65 Rs.
Current Ratio: 1.91
Interest Coverage: 18.82
Free Cash Flow: 132.45 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 63.99%

Sales Growth Qtr (YOY | QoQ):
12.55% | -34.64%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
7.51% | -3.20% | 63.99%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 37.87%

Profit Growth Qtr (YOY | QoQ):
-27.52% | -60.39%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-5.33% | -16.20% | 37.87%

EPS Rs.

EPS (TTM): 12.49 Rs.

EPS Qtr (Last Year | Latest):
2.96 Rs. | 1.28 Rs.

EPS Annual (Last Annual | Annual March):
11.80 Rs. | 10.52 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-5.33% | -16.20%

Net Profit Rs. Cr.

Net Profit (TTM): 328.82 Rs. Cr.

Net Profit (Annual - March): 264.77 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
75.37| 117.15 | 46.40

EBITDA Rs. Cr.

EBITDA (Quarter): 126.18 Rs. Cr.
EBITDA (Previous Yr Ql): 144.51 Rs. Cr.

EBITDA (Annual - March): 392.91 Rs. Cr.
EBITDA (Previous Annual): 422.88 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-2.45% | -15.05%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 28.80%

OPM Qtr (Previous | Current):
27.27% | 20.39%

OPM Annual (5 Yrs | Last Yr | March):
40.21% | 38.61% | 31.34%

Return on Equity %

ROE: 12.67%

ROE (5 Yrs | 3 Yrs | Last Yr):
21.47% | 16.75% | 14.11%

Return on Capital Employed %

ROCE: 14.89%

ROCE (5 Yrs | 3 Yrs | Last Yr):
29.48% | 22.05% | 18.78%

Return on Assets %

ROA (TTM): 8.86%

ROA (5 Yrs | 3 Yrs | Last Yr):
18.84% | 14.20% | 12.66%

PEG Ratio: -5.91
Dividend Yield: 0.00%

PE 3 Yrs: 43.56
PE 5 Yrs: 34.73

Dividend Yield: 0.00%

πŸ‘₯ Company

Cohance Lifesciences Ltd

COHANCE

Promoter Holding: %